Literature DB >> 7573921

EMLA cream prior to insertion of elective epidurals.

J A Elson1, M J Paech.   

Abstract

A randomized double-blind study was conducted in 83 women scheduled for elective caesarean section to determine the efficacy of EMLA and lignocaine infiltration for epidural insertion. The patients were randomly allocated to one of three groups: Group A (EM/LIG) received EMLA and intradermal and subdermal 1% lignocaine infiltration, Group B (EM/SAL) EMLA and saline while Group C (PL/LIG) received placebo cream and 1% lignocaine. Assessments using a 100 mm pain score were performed on skin infiltration and after subsequent insertion of a 16 gauge Tuohy needle into the supraspinous ligament. Skin changes under the applied cream and nursing rating of patients' response were also noted. Statistical analyses were performed using Kruskal-Wallis and Fisher's Exact Tests. Groups were comparable for age, weight, parity and EMLA application time (interquartile range 105-150 minutes). There were significantly higher pain scores for skin infiltration in Group C (PL/LIG) (P < 0.01) and for epidural needle insertion in Group B (EM/SAL) (P < 0.05). We concluded that in this patient population, the application of EMLA cream for at least 90 minutes plus 1% lignocaine infiltration optimized patient comfort for epidural insertion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7573921     DOI: 10.1177/0310057X9502300311

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  2 in total

1.  Use of EMLA cream for skin anesthesia and epidural insertion in the patients with cesarean delivery: A prospective double-blind randomized clinical trial.

Authors:  Katsushi Doi; Yoko Ueda; Noritaka Imamachi
Journal:  Saudi J Anaesth       Date:  2022-03-17

2.  A Needle-Free Injection System (INJEX™) with lidocaine for epidural needle insertion: A randomized controlled trial.

Authors:  Muhammet Gozdemir; Ruveyda Irem Demircioglu; Safinaz Karabayirli; Huseyin Sert; Bunyamin Muslu; Burhanettin Usta; Ummugulsum Yazici
Journal:  Pak J Med Sci       Date:  2016 May-Jun       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.